4.3 Article

ZIF-8 degrades in cell media, serum, and some-but not all-common laboratory buffers

期刊

SUPRAMOLECULAR CHEMISTRY
卷 31, 期 8, 页码 485-490

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/10610278.2019.1616089

关键词

Metal-organic frameworks; MOF; zeolitic imidazole frameworks; ZIFs; in vitro; in vivo; biocompatibility

资金

  1. National Science Foundation
  2. Cancer Prevention and Research Institute of Texas [RP170752]
  3. National Institutes of Health [1R21AI140462]
  4. American Chemical Society Petroleum Research Fund [57627-DNI10]
  5. Welch Foundation [AT-1989-20190330]
  6. Division of Materials Research [DMR1654405]
  7. [ACS-PRF 57627-DNI10]

向作者/读者索取更多资源

Drug delivery using metal-organic frameworks (MOF) has elicited interest in their biocompatibility; however, few studies have been conducted on their stability in common buffers, cell media, and blood proteins. In particular, the use of ZIF-8, a MOF interconnected by Zn and methylimidazole, has been frequently employed. In this study, we tested single crystals of ZIF-8 with common laboratory buffers, cell media, and serum, and noted several issues. Buffers containing phosphate and bicarbonate alter the appearance and composition of ZIF-8; however, these buffers do not appear to cause cargo to leak out even when the ZIF-8 itself is displaced by phosphates. On the other hand, serum dissolves ZIF-8, causing premature cargo release. Our results show that ZIF-8 undergoes surface chemistry changes that may affect the interpretation of cellular uptake and cargo release data. On the other hand, it provides a rational explanation as to how ZIF-8 neatly dissolves in vivo.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Metal-Organic Framework Encapsulated Whole-Cell Vaccines Enhance Humoral Immunity against Bacterial Infection

Michael A. Luzuriaga, Fabian C. Herbert, Olivia R. Brohlin, Jashkaran Gadhvi, Thomas Howlett, Arezoo Shahrivarkevishahi, Yalini H. Wijesundara, Sundharamani Venkitapathi, Kavya Veera, Ryanne Ehrman, Candace E. Benjamin, Sarah Popal, Michael D. Burton, Molly A. Ingersoll, Nicole J. De Nisco, Jeremiah J. Gassensmith

Summary: The increasing resistance of bacterial infections to antibiotics calls for next generation approaches to prevent potential pandemics. The development of vaccines against pathogenic bacteria has been challenging due to genetic diversity, but enhancing immunogenicity through slow releasing depots can significantly improve immune responses and survival rates.

ACS NANO (2021)

Article Chemistry, Multidisciplinary

PhotothermalPhage: A Virus-Based Photothermal Therapeutic Agent

Arezoo Shahrivarkevishahi, Michael A. Luzuriaga, Fabian C. Herbert, Alisia C. Tumac, Olivia R. Brohlin, Yalini H. Wijesundara, Abhinay Adlooru, Candace Benjamin, Hamilton Lee, Perouza Parsamian, Jashkaran Gadhvi, Nicole J. De Nisco, Jeremiah J. Gassensmith

Summary: A new generation immunophotothermal agent is developed by utilizing a chemically modified VLP called bacteriophage Q beta to adjuvant photothermal ablation. This system, named PhotothermalPhage, combines the benefits of near-infrared absorbing croconium dyes with the structure of VLPs to generate more heat and act as an immunoadjuvant, leading to effective tumor suppression and increased survival time.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Review Nanoscience & Nanotechnology

Biomaterials and nanomaterials for sustained release vaccine delivery

Michael A. Luzuriaga, Arezoo Shahrivarkevishahi, Fabian C. Herbert, Yalini H. Wijesundara, Jeremiah J. Gassensmith

Summary: Vaccines are a significant medical advancement that has prevented millions of deaths, but challenges like thermal sensitivity and required booster shots have been highlighted; integrating vaccine technology with biomaterials shows promise, offering sustained-release properties and thermal stabilization; advancements in sustained release biomaterial hold potential for infectious disease vaccines and thermally stable single-shot formulations in nanomedicine research.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)

Article Chemistry, Multidisciplinary

Supramolecular Reinforcement of a Large-Pore 2D Covalent Organic Framework

Shashini D. Diwakara, Whitney S. Y. Ong, Yalini H. Wijesundara, Robert L. Gearhart, Fabian C. Herbert, Sarah G. Fisher, Gregory T. McCandless, Sampath B. Alahakoon, Jeremiah J. Gassensmith, Sheel C. Dodani, Ronald A. Smaldone

Summary: This study successfully synthesized a novel COF called PyCOFamide, which has a pore size greater than 6 nm in diameter and shows permanent porosity and high crystallinity. The pore size of this COF is large enough to accommodate fluorescent proteins.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Nanoscience & Nanotechnology

Zeolitic Imidazolate Framework Nanoencapsulation of CpG for Stabilization and Enhancement of Immunoadjuvancy

Olivia R. Brohlin, Ryanne N. Ehrman, Fabian C. Herbert, Yalini H. Wijesundara, Arun Raja, Arezoo Shahrivarkevishahi, Shashini D. Diwakara, Ronald A. Smaldone, Jeremiah J. Gassensmith

Summary: Metal-organic frameworks (MOFs) can stabilize proteins and oligonucleotides, protecting them from degradation and increasing their immunogenicity and adjuvanticity. By encapsulating the CpG oligonucleotide in a zinc-based MOF, the DNA is protected and shows improved cellular uptake, leading to enhanced B-cell activation.

ACS APPLIED NANO MATERIALS (2022)

Article Chemistry, Multidisciplinary

Virus-like particles: a self-assembled toolbox for cancer therapy

A. Shahrivarkevishahi, L. M. Hagge, O. R. Brohlin, S. Kumari, R. Ehrman, C. Benjamin, J. J. Gassensmith

Summary: Nanoparticle-based therapeutics, specifically virus-like particles-engineered and non-infectious self-assembling systems, offer a customizable tool for designing and engineering multicomponent therapeutic agents for cancer treatments. These systems overcome key barriers in small molecule therapeutics and provide biocompatibility, degradability, and the ability for chemical modifications.

MATERIALS TODAY CHEMISTRY (2022)

Article Microbiology

Conserved FimK Truncation Coincides with Increased Expression of Type 3 Fimbriae and Cultured Bladder Epithelial Cell Association in Klebsiella quasipneumoniae

Sundharamani Venkitapathi, Yalini H. Wijesundara, Samuel A. Cornelius, Fabian C. Herbert, Jeremiah J. Gassensmith, Philippe E. Zimmern, Nicole J. De Nisco

Summary: This study investigates the role of type 1 and type 3 fimbriae, important colonization factors encoded by all Klebsiella species, in bladder epithelial cell attachment of Klebsiella quasipneumoniae in vitro. The absence of the C-terminal phosphodiesterase (PDE) domain in the FimK protein of K. quasipneumoniae leads to a loss of cross-regulation of type 3 fimbriae expression. This finding contributes to the understanding of the virulence factors of K. quasipneumoniae and its role in urinary tract infections.

JOURNAL OF BACTERIOLOGY (2022)

Article Virology

Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease

Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Victor Pashkov, Jun Dai, Jin Zhang, Fabian C. Herbert, Ramya Ramankutty Nair, Tutku Okyay, Kevin Zhu, Jeremiah J. Gassensmith, Lina Abi-Mosleh

Summary: In this study, the researchers demonstrated the efficacy and safety of a novel single-stranded DNA aptamer, AYA2012004_L, in targeting and neutralizing the uptake of SARS-CoV-2 variants. The aptamer showed promising results in in vivo and in vitro experiments, making it a potential therapeutic agent for COVID-19 management.

VIROLOGY JOURNAL (2022)

Article Multidisciplinary Sciences

Biolistic delivery of liposomes protected in metal-organic frameworks

Sneha Kumari, Yalini H. Wijesundara, Thomas S. Howlett, Mohammad Waliullah, Fabian C. Herbert, Arun Raja, Ikeda Trashi, Rodrigo A. Bernal, Jeremiah J. Gassensmith

Summary: This research explores the possibility of using biolistic delivery as an alternative to needle-and-syringe-based vaccine administration. By encapsulating liposomes in a nano-sized shell made of Zeolitic Imidazolate Framework-8 (ZIF-8), the liposomes are protected from stress and can effectively penetrate the skin. This work demonstrates the mechanical protection provided by ZIF-8 to liposomes and provides a preliminary investigation for using biolistic delivery as an alternative vaccine delivery method.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Chemistry, Multidisciplinary

In vivo biocompatibility of ZIF-8 for slow release via intranasal administration

Sneha Kumari, Thomas S. Howlett, Ryanne N. Ehrman, Shailendra Koirala, Orikeda Trashi, Ikeda Trashi, Yalini H. Wijesundara, Jeremiah J. Gassensmith

Summary: ZIF-8 shows potential in antigen protection and slow-release platform, but its biosafety in mammalian intranasal administration is not well studied. We observed slower release of ZIF-8-coated liposomes in the nasal cavity due to degradation by mucosal fluid. We found no noticeable differences in diagnostic proteins, lung diffusing capacity, and tissue morphology after administering varying doses of ZIF-8.

CHEMICAL SCIENCE (2023)

Article Chemistry, Multidisciplinary

Carrier gas triggered controlled biolistic delivery of DNA and protein therapeutics from metal-organic frameworks

Yalini H. Wijesundara, Fabian C. Herbert, Orikeda Trashi, Ikeda Trashi, Olivia R. Brohlin, Sneha Kumari, Thomas Howlett, Candace E. Benjamin, Arezoo Shahrivarkevishahi, Shashini D. Diwakara, Sachini D. Perera, Samuel A. Cornelius, Juan P. Vizuet, Kenneth J. Jr Jr Balkus, Ronald A. Smaldone, Nicole J. De Nisco, Jeremiah J. Gassensmith

Summary: This study introduces a method to achieve controlled delivery of protein, DNA, and RNA drugs by encapsulating them in ZIF-8, allowing for burst or slow release. The release profiles of these biomolecules can be modulated through judicious selection of carrier gases in the MOF-Jet.

CHEMICAL SCIENCE (2022)

Article Biochemistry & Molecular Biology

Comparative cisplatin reactivity towards human Zn7-metallothionein-2 and MTF-1 zinc fingers: potential implications in anticancer drug resistance

Anjala W. Bulathge, Rhiza Lyne E. Villones, Fabian C. Herbert, Jeremiah J. Gassensmith, Gabriele Meloni

Summary: This study investigated the preferential reactivity of cisplatin towards human Zn7MT-2, MTF-1 zinc fingers, and the entire MTF-1 zinc finger domain through in vitro competition reactions. The results demonstrated that cisplatin preferentially reacts with Zn7MT-2, releasing zinc and triggering MTF-1 activation and binding to specific DNA sequences.

METALLOMICS (2022)

暂无数据